Corrigendum to “High-Dose Subcutaneous Immunoglobulins for the Treatment of Severe Treatment-Resistant Polymyositis”

Case Reports in Rheumatology
doi 10.1155/2015/436736
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

High-Dose Subcutaneous Immunoglobulins for the Treatment of Severe Treatment-Resistant Polymyositis

Case Reports in Rheumatology
2014English

High-Dose Intravenous Immunoglobulins for the Treatment of Dermatological Autoimmune Diseases

JDDG - Journal of the German Society of Dermatology
Dermatology
2017English

Treatment of Recurrent & Resistant Dermatomyositis / Polymyositis

Egyptian Journal of Rheumatology and Clinical Immunology
2014English

Subcutaneous Immunoglobulins Are a Valuable Treatment Option in Myasthenia Gravis

Journal of Clinical Neurology (Korea
Neurology
2018English

Prognosis and Treatment of Polymyositis With Particular Reference to Steroid Resistant Patients.

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
1985English

High-Dose Glucocorticoid for the Treatment of Myeloid Sarcoma

Journal of Leukemia
2013English

High-Dose Sulbactam Treatment for Ventilator-Associated Pneumonia Caused by Carbapenem-Resistant Acinetobacter Baumannii

The Korean Journal of Critical Care Medicine
2016English

Implications of Treatment Resistant Severe Psoriasis for Benchmarking Quality of Care

Journal of Dermatological Treatment
Dermatology
2017English

Adjuvant Treatment of Severe Varicella Pneumonia With Intravenous Varicella Zoster Virus-Specific Immunoglobulins

International Journal of Infectious Diseases
MedicineInfectious DiseasesMicrobiology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy